Concepedia

Hanlin Li

HL

8

Publications

238

Citations

8

H-Index

2005

Active since

Affiliations

Pfizer (United States)(Current)

Vertex Pharmaceuticals (United States)

Eli Lilly (United States)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Takeda (United States)

Hanlin Li is an author at Pfizer (United States) specializing in medicine, drug analysis, and analytical chemistry.

Top concepts

MedicineDrug AnalysisEngineeringBiochemistryPharmacologyChromatographyAnalytical ChemistryBioanalysisReliabilityDna Replication

Publications per year

2005–2023

8

Publications

8

Comprehensive hydrophilic interaction and ion-pair reversed-phase liquid chromatography for analysis of di- to deca-oligonucleotides

Qin Li, Frédéric Lynen, Jian Wang et al. · Journal of Chromatography A · 2011 · 74 citations

Engineering, Biochemistry, Gas Chromatography +11

Dissolution Testing in Drug Product Development: Workshop Summary Report

Andreas Abend, David Curran, Jesse Kuiper et al. · The AAPS Journal · 2019 · 37 citations

Medicine, Pharmaceutical Technology, Pharmacology +2

Considerations for Updates to ICH Q1 and Q5C Stability Guidelines: Embracing Current Technology and Risk Assessment Strategies

Megan McMahon, Alexander Abbott, Yelizaveta Babayan et al. · The AAPS Journal · 2021 · 27 citations

Reliability, Ich Q1, Engineering +4

Drug Dissolution in Oral Drug Absorption: Workshop Report

Kimberly Raines, Payal Agarwal, Patrick Augustijns et al. · The AAPS Journal · 2023 · 22 citations · Full text

Prediction of the changes in drug dissolution from an immediate-release tablet containing two active pharmaceutical ingredients using an accelerated stability assessment program (ASAPprime®)

Hanlin Li, David Nadig, Andrew Kuzmission et al. · AAPS Open · 2016 · 21 citations · Full text

Rows per page

1–5 of 8